
PureTech Health has announced key progress on its ‘strategic initiatives to deliver innovative medicines to patients and unlock value for …
Mylan ended a difficult year for itself by releasing a rash of generics into the market, ending the year strongly …

Indian cancer patients could be set to receive two of the world’s leading oncology drugs, MSD’s Keytruda and Bristol-Myers Squibb’s …

